Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanquing oral solution in pediatric acute pharyngitis (Phase II)
CTR20240843Phase 2Terminated
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lanqin Oral Liquid in acute pharyngitis, sponsored by Yangtze River Pharmaceutical Group. Started Mar 2024; status: terminated.
02
Drugs
Lanqin Oral Liquid
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on CTR20240843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240843.